ATE371868T1 - Verfahren zur charakterisierung von zellen in suspension - Google Patents

Verfahren zur charakterisierung von zellen in suspension

Info

Publication number
ATE371868T1
ATE371868T1 AT97949270T AT97949270T ATE371868T1 AT E371868 T1 ATE371868 T1 AT E371868T1 AT 97949270 T AT97949270 T AT 97949270T AT 97949270 T AT97949270 T AT 97949270T AT E371868 T1 ATE371868 T1 AT E371868T1
Authority
AT
Austria
Prior art keywords
target cells
suspension
cell suspensions
particles
characterizing cells
Prior art date
Application number
AT97949270T
Other languages
English (en)
Inventor
Oystein Fodstad
Hanne Hoifodt
Original Assignee
Oystein Fodstad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oystein Fodstad filed Critical Oystein Fodstad
Application granted granted Critical
Publication of ATE371868T1 publication Critical patent/ATE371868T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97949270T 1996-12-20 1997-12-16 Verfahren zur charakterisierung von zellen in suspension ATE371868T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO965531A NO308755B1 (no) 1996-12-20 1996-12-20 FremgangsmÕte til karakterisering av unormale celler, anvendelse og sett for utførelse av fremgangsmÕten

Publications (1)

Publication Number Publication Date
ATE371868T1 true ATE371868T1 (de) 2007-09-15

Family

ID=19900214

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97949270T ATE371868T1 (de) 1996-12-20 1997-12-16 Verfahren zur charakterisierung von zellen in suspension

Country Status (9)

Country Link
US (1) US8097429B2 (de)
EP (1) EP0951645B1 (de)
AT (1) ATE371868T1 (de)
AU (1) AU728190B2 (de)
CA (1) CA2275335C (de)
DE (1) DE69738076T2 (de)
ES (1) ES2293663T3 (de)
NO (1) NO308755B1 (de)
WO (1) WO1998028622A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642062B2 (en) * 1998-09-03 2003-11-04 Trellis Bioinformatics, Inc. Multihued labels
US6828157B1 (en) 1999-05-04 2004-12-07 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6682940B2 (en) 1999-05-04 2004-01-27 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
GB9913556D0 (en) * 1999-06-11 1999-08-11 Zeneca Ltd Assays
WO2002036833A1 (en) * 2000-11-06 2002-05-10 Bio-Tech Imaging, Inc. Method and kits for detecting hepatitis infected cells
US6939670B2 (en) * 2001-03-12 2005-09-06 Monogen, Inc. Cell-based detection and differentiation of lung cancer
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
WO2002097395A2 (en) * 2001-05-31 2002-12-05 Chiron Corporation P-cadherin as a target for anti-cancer therapy
EP1474772A4 (de) * 2002-02-14 2005-11-09 Immunivest Corp Verfahren und algorithmen zur zellenaufzählung in einem kostengünstigen zytometer
TW200521433A (en) * 2003-12-22 2005-07-01 We Gene Technologies Inc Cell detection chip and fabricating method thereof and method of detecting cell
US8189899B2 (en) 2004-07-30 2012-05-29 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
EP2029779A4 (de) 2006-06-14 2010-01-20 Living Microsystems Inc Verwendung hoch paralleler snp-genotypisierung zur fötalen diagnose
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP2589668A1 (de) 2006-06-14 2013-05-08 Verinata Health, Inc Analyse seltener Zellen mittels Probentrennung und DNA-Etiketten
EP2126579A2 (de) * 2007-02-27 2009-12-02 Sentoclone AB Multiplex-nachweis von tumorzellen unter verwendung einer gruppe von an extrazelluläre marker bindenden agentien
CN101855553B (zh) * 2007-06-29 2014-06-11 韩国安国药品株式会社 卵巢癌的预测标记
ES2620012T3 (es) 2008-09-20 2017-06-27 The Board Of Trustees Of The Leland Stanford Junior University Diagnóstico no invasivo de la aneuploidia fetal por secuenciación
CN102432685A (zh) * 2011-11-01 2012-05-02 中国环境科学研究院 检测重组小鼠碱性成纤维细胞生长因子的免疫胶乳微球及其制备方法和应用
WO2014104019A1 (ja) * 2012-12-26 2014-07-03 デンカ生研株式会社 尿中ポドサイトの検出方法
DE102013106432A1 (de) * 2013-06-20 2014-12-24 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Optische Indikator-Einheit und Vorrichtung und Verfahren zur Bestimmung einer physikalisch-chemischen Eigenschaft eines Prozessmediums in einer prozesstechnischen Anlage
CA2992370A1 (en) * 2015-04-06 2016-10-13 University Of Miami Imaging device and method for detection of disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
JPH07104349B2 (ja) * 1987-04-11 1995-11-13 株式会社日立製作所 細胞測定法
US5194300A (en) * 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
FR2638848B1 (fr) * 1988-11-04 1993-01-22 Chemunex Sa Procede de detection et/ou de dosage dans un milieu liquide ou semi-liquide d'au moins une substance organique, biologique ou medicamenteuse soluble, par une methode d'agglutination
FR2638849B1 (fr) * 1988-11-04 1994-03-18 Chemunex Sa Procede d'amplification d'un signal fluorescent pour la recherche specifique de la presence eventuelle de particules et application a la detection et a la numeration desdites particules
US5340719A (en) * 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
AU2115092A (en) * 1991-10-08 1993-04-22 Eastman Kodak Company Method, test device and kit for assay of specific binding ligand using controlled flow through filtration membrane
US5290707A (en) * 1991-11-25 1994-03-01 The United States Of America As Represented By The Secretary Of The Army Method for detection of microorganisms
US5256542A (en) * 1992-03-09 1993-10-26 Tanox Biosystems, Inc. Selecting low frequency antigen-specific single B lymphocytes with correction for background noise
WO1994007138A1 (en) * 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
ES2216034T3 (es) * 1992-09-14 2004-10-16 Sri International Indicadores de conversion creciente destinados a ensayos biologicos y otros utilizando tecnicas de excitacion por laser.
US5374531A (en) * 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
AUPN214095A0 (en) * 1995-04-03 1995-04-27 Australian Water Technologies Pty Ltd Method for detecting microorganisms using flow cytometry

Also Published As

Publication number Publication date
CA2275335A1 (en) 1998-07-02
AU7875298A (en) 1998-07-17
DE69738076D1 (de) 2007-10-11
US8097429B2 (en) 2012-01-17
DE69738076T2 (de) 2008-05-21
WO1998028622A1 (en) 1998-07-02
NO308755B1 (no) 2000-10-23
US20050130234A1 (en) 2005-06-16
AU728190B2 (en) 2001-01-04
EP0951645B1 (de) 2007-08-29
CA2275335C (en) 2008-02-12
ES2293663T3 (es) 2008-03-16
NO965531L (no) 1998-06-22
NO965531D0 (no) 1996-12-20
EP0951645A1 (de) 1999-10-27

Similar Documents

Publication Publication Date Title
DE69738076D1 (de) Verfahren zur Charakterisierung von Zellen in Suspension
DE60019111D1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
DE69113872D1 (de) Biologisch aktive Reagenzien aus Carboxylgruppenhaltigen Polymerisaten, analytisches Element und Verfahren zur Verwendung.
ATE1648T1 (de) Verfahren zur magnetischen abtrennung von zellen und dgl. und dabei zu verwendende mikrosphaeren.
MY100973A (en) Immuno- agglutination suspensions
DE3579059D1 (de) Apparat zur beschichtung von kernbrennstoffpartikeln mit einem brennbaren absorber.
ATE150871T1 (de) Verfahren zur herstellung von biologisch aktiven reagentien aus succinimid enthaltenden polymeren, analytisches element und verwendungsmethoden
CA2093415A1 (en) Test method and reagent kit therefor
ATE177533T1 (de) Verfahren zur bestimmung einer immunologischen aktiven substanz mittels magnetischer latexteilchen und nichtmagnetischer teilchen
CA2146735A1 (en) Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes
DE69830602D1 (de) Teilchen
DE59914768D1 (de) Entstörung von Immunoassays durch Substanzen, die aus den Framework-Regionen von Antikörpern abgeleitet sind
ATE292513T1 (de) Verfahren zur vorbehandlung von membanen
ES8604353A1 (es) Procedimiento de formacion de un material laminar para la ligacion de sustancias biologicas contenidas en una muestra analitica
DE3751331D1 (de) Nachweisverfahren eines zellenoberflächenantigens.
ATE53912T1 (de) Verfahren zur konzentrierung und bestimmung von biomolekuelen und zellen.
NZ515852A (en) Products and methods for single parameter and multiparameter phenotyping of cells
Hydén et al. Proteins S-100 and 14-3-2 in nerve cells of rats raised in enriched and impoverished environments: Distribution, quantification, and cell separation by surface antigens
DE69612865D1 (de) Partikelförmiges medium zur genauen trennung von in fluiden suspendierten teilchen
ATE132896T1 (de) Methoden zur verwendung von an humanen klasse-ii- histokompatibilitätsantigenen mangelnden zellinien
FI843562A0 (fi) Foerfarande foer immunokemisk bestaemning av hepatitis b kaernantigener.
Dudnik et al. The behavior of nucleolar proteins under the conditions of the reversible three-dimensional separation of the structural components of the nucleolus
ATE269971T1 (de) Verfahren zur prüfung von immunokompetenz
DE59913949D1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2
TW271466B (en) Rapid identification of vibrio parahaemolyticus by latex agglutination test

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties